The global market for Proteomics was estimated at US$37.4 Billion in 2024 and is projected to reach US$66.7 Billion by 2030, growing at a CAGR of 10.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Proteomics market.
Recent advancements in proteomics have significantly enhanced its capabilities and applications. High-resolution mass spectrometry and advanced bioinformatics tools have improved the accuracy and efficiency of protein identification and quantification. Innovations such as next-generation sequencing and CRISPR technology have facilitated the integration of proteomics with genomics and transcriptomics, providing a more comprehensive understanding of cellular processes. Additionally, the development of single-cell proteomics is opening new avenues for studying cellular heterogeneity and disease progression at an unprecedented resolution. These technological advancements are driving the adoption of proteomics in various fields, including drug discovery, personalized medicine, and clinical diagnostics, as they enable more precise and detailed analysis of the proteome.
The growth in the proteomics market is driven by several factors. The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases has heightened the demand for advanced diagnostic and therapeutic solutions, spurring the adoption of proteomics. The shift towards personalized medicine, which relies on understanding individual proteomic profiles to tailor treatments, is also a significant driver. Factors supporting growth also include development of protein targeted treatments and precision molecular medicines for many autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Increasing focus of biotechnological and pharmaceutical companies in research and development for identifying new proteomics applications, development of new drugs, and proteomics biomarker discovery in different types of diseases such as cardiovascular diseases and cancer is the major trend in the global proteomics landscape. Technological advancements in mass spectrometry and bioinformatics are enhancing the capabilities of proteomic analysis, making it more accessible and cost-effective. Furthermore, the expansion of research in areas such as biomarker discovery and drug development is fueling market growth. Government and private sector investments in proteomics research and infrastructure, coupled with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market`s expansion. These factors, along with the growing recognition of proteomics as a critical tool in life sciences research, are propelling the growth of the proteomics market.
Global Proteomics Market - Key Trends & Drivers Summarized
Proteomics is the large-scale study of proteins, their structures, functions, and interactions within a biological system. As proteins are essential to nearly every cellular process, proteomics provides crucial insights into how cells function and how diseases develop. Techniques used in proteomics include mass spectrometry, protein microarrays, and various bioinformatics tools to identify and quantify proteins, analyze protein modifications, and map protein-protein interactions. These techniques allow scientists to explore the proteome, the entire set of proteins produced by an organism, tissue, or cell. By comparing proteomes under different conditions, researchers can identify disease biomarkers, understand disease mechanisms, and develop targeted therapies, making proteomics indispensable in biomedical research.Recent advancements in proteomics have significantly enhanced its capabilities and applications. High-resolution mass spectrometry and advanced bioinformatics tools have improved the accuracy and efficiency of protein identification and quantification. Innovations such as next-generation sequencing and CRISPR technology have facilitated the integration of proteomics with genomics and transcriptomics, providing a more comprehensive understanding of cellular processes. Additionally, the development of single-cell proteomics is opening new avenues for studying cellular heterogeneity and disease progression at an unprecedented resolution. These technological advancements are driving the adoption of proteomics in various fields, including drug discovery, personalized medicine, and clinical diagnostics, as they enable more precise and detailed analysis of the proteome.
The growth in the proteomics market is driven by several factors. The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases has heightened the demand for advanced diagnostic and therapeutic solutions, spurring the adoption of proteomics. The shift towards personalized medicine, which relies on understanding individual proteomic profiles to tailor treatments, is also a significant driver. Factors supporting growth also include development of protein targeted treatments and precision molecular medicines for many autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Increasing focus of biotechnological and pharmaceutical companies in research and development for identifying new proteomics applications, development of new drugs, and proteomics biomarker discovery in different types of diseases such as cardiovascular diseases and cancer is the major trend in the global proteomics landscape. Technological advancements in mass spectrometry and bioinformatics are enhancing the capabilities of proteomic analysis, making it more accessible and cost-effective. Furthermore, the expansion of research in areas such as biomarker discovery and drug development is fueling market growth. Government and private sector investments in proteomics research and infrastructure, coupled with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market`s expansion. These factors, along with the growing recognition of proteomics as a critical tool in life sciences research, are propelling the growth of the proteomics market.
SCOPE OF STUDY:
The report analyzes the Proteomics market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Component (Reagents, Instruments, Services); Application (Drug Discovery, Disease Diagnosis, Other Applications)
- Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Reagents segment, which is expected to reach US$49.2 Billion by 2030 with a CAGR of a 10.0%. The Instruments segment is also set to grow at 11.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $13.8 Billion in 2024, and China, forecasted to grow at an impressive 12.8% CAGR to reach $6.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Proteomics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Proteomics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Proteomics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Active Motif, Inc., 20/20 Genesystems, Inc., BG Medicine, Inc., BGI-Shenzhen, Biodesix, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 178 companies featured in this Proteomics market report include:
- Active Motif, Inc.
- 20/20 Genesystems, Inc.
- BG Medicine, Inc.
- BGI-Shenzhen
- Biodesix, Inc.
- Abbiotec LLC
- BioChain Institute, Inc.
- Arbor Vita Corporation
- Biomosaics, Inc.
- Advansta Inc.
- AYOXXA Biosystems GmbH
- AKESOgen, Inc.
- Biognosys
- Biorbyt
- BioAnalyte
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Active Motif, Inc.
- 20/20 Genesystems, Inc.
- BG Medicine, Inc.
- BGI-Shenzhen
- Biodesix, Inc.
- Abbiotec LLC
- BioChain Institute, Inc.
- Arbor Vita Corporation
- Biomosaics, Inc.
- Advansta Inc.
- AYOXXA Biosystems GmbH
- AKESOgen, Inc.
- Biognosys
- Biorbyt
- BioAnalyte
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 577 |
| Published | July 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 37.4 Billion |
| Forecasted Market Value ( USD | $ 66.7 Billion |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Global |
